Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines

BACKGROUND: The Middle East respiratory syndrome coronavirus (MERS-CoV) is a pathogen associated with an acute respiratory infection that has a high mortality rate in humans. It was first identified in June of 2012 in the Arabian Peninsula. The success of the COVID-19 vaccines has shown that it is p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandeel, Mahmoud, Morsy, Mohamed A., Abd El-Lateef, Hany M., Marzok, Mohamed, El-Beltagi, Hossam S., Al Khodair, Khalid M., Albokhadaim, Ibrahim, Venugopala, Katharigatta N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050282/
https://www.ncbi.nlm.nih.gov/pubmed/37004348
http://dx.doi.org/10.1016/j.intimp.2023.109998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050282/
https://www.ncbi.nlm.nih.gov/pubmed/37004348
http://dx.doi.org/10.1016/j.intimp.2023.109998

Ejemplares similares